GT Biopharma (GTBP) Total Non-Current Liabilities (2009 - 2025)
GT Biopharma (GTBP) posted Total Non-Current Liabilities of -$8.68 million for Q4 2025, compared with $5.65 million a year earlier.
Powered by 
Analysis
GT Biopharma (GTBP) Total Non-Current Liabilities (2009 - 2025) Analysis & Trends
Since Q1 2009, GT Biopharma has reported Total Non-Current Liabilities for 57 quarters.
- In prior years, GT Biopharma's Total Non-Current Liabilities was $5.65 million in FY2024 (+1.2%), $5.58 million in FY2023 (+12.0%), $4.98 million in FY2022 (-50.8%) and $10.12 million in FY2021 (-70.8%).
- The Q4 2025 figure stands as the lowest quarterly Total Non-Current Liabilities since Q1 2013.
- On a year-over-year basis, Total Non-Current Liabilities increased in five of the last six quarters, with growth averaging 140.7%.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q2 2025, with growth of 840.8%; the weakest was Q4 2021, with a decline of 70.8%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was -$6.68 million (Q3 2025), $32.76 million (Q2 2025) and $3.51 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 96.04 Bn |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -8.68 Mn |
| Sep 30, 2025 | -6.68 Mn |
| Jun 30, 2025 | 32.76 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 5.65 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Jun 30, 2024 | 3.48 Mn |
| Mar 31, 2024 | 4.21 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 3.99 Mn |
| Jun 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 4.11 Mn |
| Dec 31, 2022 | 4.98 Mn |
| Sep 30, 2022 | 5.06 Mn |
| Jun 30, 2022 | 8.62 Mn |
| Mar 31, 2022 | 9.53 Mn |
| Dec 31, 2021 | 10.12 Mn |
| Sep 30, 2021 | 3.58 Mn |
| Jun 30, 2021 | 2.43 Mn |
| Mar 31, 2021 | 3.26 Mn |
API Access
GT Biopharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();